These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 55394)

  • 1. Inhibition of allergic reactions by chromoglycate and by a new anti-allergic drug (10-chloro-1,4,6,9-tetrahydro-4,6-dioxopyrido (3,2-g) quinoline-2,8-dicardoxylic acid). I. Activity in rats.
    Johnson HG; van Hout CA
    Int Arch Allergy Appl Immunol; 1976; 50(4):446-53. PubMed ID: 55394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of allergic reactions by cromoglycate and by a new anti-allergy drug U-42,585E. I. Activity in rats.
    Johnson HG; VanHout CA; Wright JB
    Int Arch Allergy Appl Immunol; 1978; 56(5):416-23. PubMed ID: 75851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of allergic reactions by cromoglycate and by a new anti-allergic drug(10-chloro-1,4,6,9-tetrahydro-4,6-dioxopyrido(3,2-g)quinoline-2,8-dicarboxylic acid). II. Activity in primates against aerosolized Ascaris suum antigen.
    Johnson HG; van Hout CA
    Int Arch Allergy Appl Immunol; 1976; 50(4):454-62. PubMed ID: 814103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of immediate hypersensitivity reactions in the rat by ICI 74,917 and disodium cromoglycate.
    Evans DP; Marshall PW; Thomson DS
    Int Arch Allergy Appl Immunol; 1975; 49(4):417-27. PubMed ID: 51008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and antiallergic activities of 1,3-oxazolo[4,5-h]quinolines.
    Musser JH; Jones H; Sciortino S; Bailey K; Coutts SM; Khandwala A; Sonnino-Goldman P; Leibowitz M; Wolf P; Neiss ES
    J Med Chem; 1985 Sep; 28(9):1255-9. PubMed ID: 2411926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the anti-anaphylactic activities of salbutamol and disodium cromoglycate in the rat, the rat mast cell and in human lung tissue.
    Butchers PR; Fullarton JR; Skidmore IF; Thompson LE; Vardey CJ; Wheeldon A
    Br J Pharmacol; 1979 Sep; 67(1):23-32. PubMed ID: 115530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-allergic effects of ketanserin on animal models of allergic reactions.
    Nagai H; Suda H; Kitagaki K; Goto S; Miura T; Koda A
    Arch Int Pharmacodyn Ther; 1990; 307():172-82. PubMed ID: 1710442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of quinotolast, a new orally active antiallergic drug, on experimental allergic models.
    Kobayashi K; Hiroi J; Kishi S; Sawase K; Hirayama Y; Chihara S; Imai T; Shigi Y; Shimomura K; Kohsaka M
    Jpn J Pharmacol; 1993 Sep; 63(1):73-81. PubMed ID: 7505860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacology of a new orally active antiallergic: pyrido[1,2-a]pyrimidine, ucb L140 (CHINOIN 1045) in rats.
    De Vos C; Dessy F; Hermecz I; Meszaros Z; Breining T
    Int Arch Allergy Appl Immunol; 1982; 67(4):362-8. PubMed ID: 6175586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of immediate hypersensitivity reactions by disodium cromoglycate.
    Thomson DS; Evans DP
    Clin Exp Immunol; 1973 Apr; 13(4):537-44. PubMed ID: 4123820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The inhibition of histamine release by antiallergic drugs.
    Nagai H; Kelly K; Sehon AH
    Int Arch Allergy Appl Immunol; 1978; 56(4):307-15. PubMed ID: 75849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ro 22-3747: a new antiallergic agent for the treatment of immediate hypersensitivity diseases.
    Welton AF; Hope WC; O'Donnell M; Baruth H; Crowley HJ; Miller DA; Yaremko B
    J Pharmacol Exp Ther; 1984 Jan; 228(1):57-64. PubMed ID: 6198511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Inhibitory effect on the release of mediators from rat peritoneal exudate cells and the antagonistic effect against mediators of MY-5116 and other anti-allergic agents].
    Yamada N; Takahashi K; Endoh K; Arai Y
    Nihon Yakurigaku Zasshi; 1986 Sep; 88(3):229-37. PubMed ID: 2431983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of nedocromil sodium in mast-cell-dependent reactions in the rat.
    Riley PA; Mather ME; Keogh RW; Eady RP
    Int Arch Allergy Appl Immunol; 1987; 82(1):108-10. PubMed ID: 3026967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiallergic activity profiles in vitro of RHC 3164 and related compounds. II. Comparison of RHC 3164 with disodium cromoglycate.
    Khandwala A; Dally-Meade V; Jariwala N; Huang F
    Int Arch Allergy Appl Immunol; 1984; 73(1):65-70. PubMed ID: 6198288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of SA-103 on experimental allergic models in vivo and in vitro--comparison with disodium cromoglycate.
    Nabe T; Yamamura H; Kohno S; Ohata K
    Arerugi; 1992 Jun; 41(6):676-85. PubMed ID: 1280084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mechansim of tachyphylaxis to ICI 74,917 and disodium cromoglycate.
    Marshall PW; Thomson DS; Evans DP
    Int Arch Allergy Appl Immunol; 1976; 51(3):274-83. PubMed ID: 58840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of allergic reactions by a novel phenanthroline ICI 74,917.
    Evans DP; Gilman DJ; Thomson DS; Waring WS
    Nature; 1974 Aug; 250(467):592-3. PubMed ID: 4136035
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of disodium cromoglycate on mast cell-mediated immediate-type allergic reactions.
    Shin HY; Kim JS; An NH; Park RK; Kim HM
    Life Sci; 2004 Apr; 74(23):2877-87. PubMed ID: 15050425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of IgE-dependent histamine release from human dispersed lung mast cells by anti-allergic drugs and salbutamol.
    Church MK; Hiroi J
    Br J Pharmacol; 1987 Feb; 90(2):421-9. PubMed ID: 2435353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.